Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Gilead Sciences
Vanderbilt-Ingram Cancer Center
M.D. Anderson Cancer Center
Gilead Sciences
University College, London
TCR2 Therapeutics
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
Massachusetts General Hospital